Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

802 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Generic drugs in oncology - Authors' reply.
Bennett CL, Nagai S, Yang YT, Chen BK, Sartor O, Armitage JO. Bennett CL, et al. Among authors: yang yt. Lancet Oncol. 2017 Feb;18(2):e64. doi: 10.1016/S1470-2045(17)30016-5. Lancet Oncol. 2017. PMID: 28214418 No abstract available.
Generic oncology drugs: are they all safe?
Yang YT, Nagai S, Chen BK, Qureshi ZP, Lebby AA, Kessler S, Georgantopoulos P, Raisch DW, Sartor O, Hermanson T, Kane RC, Hrushesky WJ, Riente JJ, Norris LB, Bobolts LR, Armitage JO, Bennett CL. Yang YT, et al. Lancet Oncol. 2016 Nov;17(11):e493-e501. doi: 10.1016/S1470-2045(16)30384-9. Lancet Oncol. 2016. PMID: 27819247 Review.
"Right-to-Try" Legislation: Progress or Peril?
Yang YT, Chen B, Bennett C. Yang YT, et al. J Clin Oncol. 2015 Aug 20;33(24):2597-9. doi: 10.1200/JCO.2015.62.8057. Epub 2015 Jul 20. J Clin Oncol. 2015. PMID: 26195722 No abstract available.
Biosimilars-Curb Your Enthusiasm.
Yang YT, Chen B, Bennett CL. Yang YT, et al. JAMA Oncol. 2017 Nov 1;3(11):1467-1468. doi: 10.1001/jamaoncol.2017.1530. JAMA Oncol. 2017. PMID: 28594963 No abstract available.
Friction in the Path to Use of Biosimilar Drugs.
Chen B, Yang YT, Bennett C. Chen B, et al. Among authors: yang yt. N Engl J Med. 2018 May 31;378(22):2148. doi: 10.1056/NEJMc1805092. N Engl J Med. 2018. PMID: 29847904 No abstract available.
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions.
Bennett CL, Schooley B, Taylor MA, Witherspoon BJ, Godwin A, Vemula J, Ausdenmoore HC, Sartor O, Yang YT, Armitage JO, Hrushesky WJ, Restaino J, Thomsen HS, Yarnold PR, Young T, Knopf KB, Chen B. Bennett CL, et al. Among authors: yang yt. PLoS One. 2019 Jul 31;14(7):e0219521. doi: 10.1371/journal.pone.0219521. eCollection 2019. PLoS One. 2019. PMID: 31365527 Free PMC article.
End of an era for erythropoiesis-stimulating agents in oncology.
Schoen MW, Hoque S, Witherspoon BJ, Schooley B, Sartor O, Yang YT, Yarnold PR, Knopf KB, Hrushesky WJM, Dickson M, Chen BJ, Nabhan C, Bennett CL. Schoen MW, et al. Among authors: yang yt. Int J Cancer. 2020 May 15;146(10):2829-2835. doi: 10.1002/ijc.32917. Epub 2020 Feb 28. Int J Cancer. 2020. PMID: 32037527 Free article.
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.
Bennett CL, Schoen MW, Hoque S, Witherspoon BJ, Aboulafia DM, Hwang CS, Ray P, Yarnold PR, Chen BK, Schooley B, Taylor MA, Wyatt MD, Hrushesky WJ, Yang YT. Bennett CL, et al. Among authors: yang yt. Lancet Oncol. 2020 Dec;21(12):e575-e588. doi: 10.1016/S1470-2045(20)30485-X. Lancet Oncol. 2020. PMID: 33271114 Review.
802 results